Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Phone Reviews
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Phone Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / Big setback: Serum pauses Oxford's coronavirus vaccine trial in India
  • India

    Big setback: Serum pauses Oxford's coronavirus vaccine trial in India

    Shalini Ojha
    Written by
    Shalini Ojha
    Twitter
    Last updated on Sep 10, 2020, 04:24 pm
    Big setback: Serum pauses Oxford's coronavirus vaccine trial in India
  • A day after deciding to not halt the trial of the coronavirus vaccine, developed by the University of Oxford in collaboration with UK-pharma giant AstraZeneca, the Serum Institute of India (SII) on Thursday said it was also pausing the process.

    This development came hours after the Drugs Controller General of India (DCGI) served a show-cause notice to the vaccine manufacturer.

    Here are more details.

  • In this article
    Background: AstraZeneca paused trials after volunteer fell ill Despite global halt, SII continued with the trials SII's decision earned it a searing letter from DCGI Pausing trials, will restart after AstraZeneca does: SII Earlier, Poonawalla was certain vaccine would be available by December
  • Context

    Background: AstraZeneca paused trials after volunteer fell ill

    Background: AstraZeneca paused trials after volunteer fell ill
  • AstraZeneca and Oxford's candidate, that raised hopes globally, ran into a predicament after one volunteer of the UK developed an "adverse reaction."

    Saying that the matter was being probed and a reaction was not uncommon in large-scale trials, AstraZeneca paused the global process.

    Later, CEO Pascal Soriot said the volunteer, a woman, had "neurological symptoms consistent with a rare but serious spinal inflammatory disorder."

  • What happened

    Despite global halt, SII continued with the trials

  • The fact that trials were stopped served as disappointing news for the world, which has lost 908,522 to the deadly virus. Experts said this setback would affect other vaccine candidates as well.

    However, SII, the Pune-based company which partnered with AstraZeneca to mass-produce the vaccine, decided to continue the trials.

    The vaccine entered Stage-2/3 trials in 17 sites across India last month.

  • Letter

    SII's decision earned it a searing letter from DCGI

    SII's decision earned it a searing letter from DCGI
  • By last evening, DCGI sent a scathing show-cause notice to SII asking why the body was not informed about AstraZeneca's development.

    The body pointed out that SII didn't submit "casualty analysis of the reported serious adverse event," and asked why should the permission to conduct trials at home not be canceled.

    Director Dr. VG Somani told SII to explain its rationale or face repercussions.

  • Details

    Pausing trials, will restart after AstraZeneca does: SII

    Pausing trials, will restart after AstraZeneca does: SII
  • Following the notice, SII said it would be following all the guidelines of the drug regulator, adding that it hadn't received orders about halting trials just yet.

    "Nothing untoward has been reported during the vaccine trials in India," CEO Adar Poonwalla said yesterday.

    However, taking a contradictory position today, SII said trials have been paused. The process will restart after AstraZeneca resumes theirs.

  • Timeline

    Earlier, Poonawalla was certain vaccine would be available by December

  • This significant development could immensely affect the vaccine timeline, though AstraZeneca assured it was working toward mitigating the effect.

    To recall, Poonawalla had also expressed confidence that Covishield (the name given to the vaccine), would be available in India by December 2020.

    He had also revealed that manufacturing will begin before final results arrive to ensure there is no shortage of doses.

  • Oxford
  • University of Oxford
  • Coronavirus
  • Serum Institute of India
  • AstraZeneca
  •  
Latest News
  • Maharashtra: Can house helps go to work amid fresh restrictions?
    Maharashtra: Can house helps go to work amid fresh restrictions?
    India
  • Ben Stokes ruled out of IPL 2021 with broken finger
    Ben Stokes ruled out of IPL 2021 with broken finger
    Sports
  • Biden to withdraw US troops from Afghanistan before 9/11 anniversary
    Biden to withdraw US troops from Afghanistan before 9/11 anniversary
    World
  • Coronavirus: India reports biggest single-day spike with 1.85L new cases
    Coronavirus: India reports biggest single-day spike with 1.85L new cases
    India
  • NewsBytes Briefing: Your WhatsApp account isn't safe anymore, and more
    NewsBytes Briefing: Your WhatsApp account isn't safe anymore, and more
    Science
Related Timelines
  • Coronavirus vaccine consignment awaits government nod for take-off from Pune
    Coronavirus vaccine consignment awaits government nod for take-off from Pune
    India
  • Trial will continue: Centre on SII vaccine's "adverse reaction" claims
    Trial will continue: Centre on SII vaccine's "adverse reaction" claims
    India
  • SII says Covishield 'safe' after trial participant sends legal notice
    SII says Covishield 'safe' after trial participant sends legal notice
    Science
  • Russia's Sputnik V to start human trials in India soon
    Russia's Sputnik V to start human trials in India soon
    Science
Trending Topics
ISRO Vaccine
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Chris Lynn Samsung Virat Kohli
Rohit Sharma Cricket News Mahendra Singh Dhoni YouTube Hollywood News WhatsApp Bollywood News Real Madrid ISRO Yoga
Honda Batman Football News BMW Vaccine Reliance Jio OPPO Food News, Healthy Recipes Apple Tesla
Royal Challengers Bangalore Toyota Fashion Tips Amit Shah Mercedes Sidharth Malhotra Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV
Smart TV Marvel Comics Avengers Neha Kakkar
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021